Deirdre R. Pachman, M.D.

  1. Mokshagundam S, McGree ME, Tapia AL, Fought AJ, Ishitani KP, Lee MK, Dowdy SC, Yadav S, Pachman DR, Kumar A. Physical and psychological distress amongst patients undergoing neoadjuvant chemotherapy for advanced ovarian cancer. Gynecol Oncol. 2024 Nov; 190:230-235 Epub 2024 Sept 05
    View PubMed
  2. Griffin J, Ruddy K, Chlan L, O'Connor M, Pachman D, Podratz J, Rahman P, Richardson K, Ridgeway J, Rutten L, Schaepe K, Tofthagen C, McCleary NJ, Merle JL, Richardson JE, Bass M, Garcia SF, Cheville AL, Mitchell SA, Jensen R, Minteer S, Austin JD, Tesch N, DiMartino L, Hassett MJ, Osarogiagbon RU, Wong S, Schrag D, Cella D, Smith AW, Smith JD, IMPACT Consortium. Bridging clinical informatics and implementation science to improve cancer symptom management in ambulatory oncology practices: experiences from the IMPACT consortium. JAMIA Open. 2024 Oct; 7 (3):ooae081 Epub 2024 Sept 04
    View PubMed
  3. Tofthagen C, Sheffield K, Pachman DR, Mandrekar J, Szalacha LA, Chesak SS, Rhudy LM, Kilpatrick M, Buck H. Accelerated Resolution Therapy for Early Maladaptive Grief Study Protocol. Am J Hosp Palliat Care. 2024 Sep 5; 10499091241282417 Epub 2024 Sept 05
    View PubMed
  4. Austin JD, Finney Rutten LJ, Fischer K, Ridgeway J, Minteer S, Griffin JM, Pachman DR, Ruddy KJ, Cheville A. Advancing Care Team Adoption of Electronic Health Record Systems for Cancer Symptom Management: Findings From a Hybrid Type II, Cluster-Randomized, Stepped-Wedge Trial. JCO Oncol Pract. 2024 Aug 6; OP2400280 Epub 2024 Aug 06
    View PubMed
  5. Kennard A, Low Dog T, Clinkenbeard J, Pachman D, Iozzi D. Contemplative medicine: A practical approach to "Well-Being 2.0" in medicine. Explore (NY). 2024 May-Jun; 20 (3):439-442 Epub 2023 Nov 10
    View PubMed
  6. Ridgeway JL, Cheville AL, Fischer KJ, Tesch NK, Austin JD, Minteer SA, Pachman DR, Chlan LL, Ruddy KJ, Griffin JM. Tracking activities and adaptations in a multi-site stepped wedge pragmatic trial of a cancer symptom management intervention. Contemp Clin Trials Commun. 2024 Apr; 38:101269 Epub 2024 Feb 09
    View PubMed
  7. Pachman DR. I suffer too. Palliat Support Care. 2024 Feb; 22 (1):190-191
    View PubMed
  8. Griffin J, Austin J, Chlan L, O'Connor M, Pachman D, Podratz J, Rahman P, Ridgeway J, Rutten L, Schaepe K, Tesch N, Tofthagen C, Smith AW, DiMartino L, Garcia SF, Mitchell SA, Ruddy KJ, Smith JD, Wong SL, Cahue S, Cella D, Jensen RE, Hassett MJ, Hodgdon C, Kroner B, Osarogiagbon RU, Popovic J, Richardson K, Schrag D, Cheville AL, IMPACT Consortium. Systematic symptom management in the IMPACT Consortium: rationale and design for 3 effectiveness-implementation trials. JNCI Cancer Spectr. 2023 Oct 31; 7 (6)
    View PubMed
  9. Kroenke K, Lam V, Ruddy KJ, Pachman DR, Herrin J, Rahman PA, Griffin JM, Cheville AL. Prevalence, Severity, and Co-Occurrence of SPPADE Symptoms in 31,866 Patients With Cancer. J Pain Symptom Manage. 2023 May; 65 (5):367-377 Epub 2023 Feb 02
    View PubMed
  10. Chesak SS, Dose AM, Mandrekar J, James D, Pachman DR, Cutshall S, Fuehrer DL, Sood A. Outcomes of a Stress Management and Resiliency Training (SMART) Program for Family Caregivers of Individuals With Advanced Head and Neck Cancer. Oncol Nurs Forum. 2022 Dec 16; 50 (1):6-18
    View PubMed
  11. Williams C, Chesak S, Pachman DR, Rhee L, Dierkhising R, Leventakos K. Feasibility of virtual stress management and resiliency training (smart) for oncology fellows during the covid-19 pandemic. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 2022; 40(16 Suppl):11016.
  12. Wintheiser GA, Ruddy KJ, Herrin J, Rahman PA, Pachman DR, Leppin AL, Rutten LJF, Lee MK, Griffin JM, Tofthagen C, Chlan LL, Ridgeway JL, Mitchell SA, Cheville AL. Receptivity to a Nurse-Led Symptom Management Intervention Among Highly Symptomatic Patients With Cancer. J Natl Cancer Inst. 2022 Mar 08; 114(3):458-466.
    View PubMed
  13. Weng J, Pachman DR, Wild E, Ingram CJ. Dignity Conserving Therapy: An Intervention for Addressing Psychosocial and Existential Distress in Patients with Serious Illness. Palliat Med Rep. 2022; 3 (1):206-210 Epub 2022 Sept 16
    View PubMed
  14. Albany C, Dockter T, Wolfe E, Le-Rademacher J, Wagner-Johnston N, Einhorn L, Lafky JM, Smith E, Pachman D, Staff N, Ma C, Loprinzi CL, Costello BA. Correction to: Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724). Support Care Cancer. 2021 Nov; 29 (11):7129-7130
    View PubMed
  15. Yang J, Wahner-Roedler DL, Zhou X, Johnson LA, Do A, Pachman DR, Chon TY, Salinas M, Millstine D, Bauer BA. Acupuncture for palliative cancer pain management: systematic review. BMJ Support Palliat Care. 2021 Sep; 11 (3):264-270 Epub 2021 Jan 13
    View PubMed
  16. Albany C, Dockter T, Wolfe E, Le-Rademacher J, Wagner-Johnston N, Einhorn L, Lafky JM, Smith E, Pachman D, Staff N, Ma C, Loprinzi CL, Costello BA. Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724). Support Care Cancer. 2021 Feb; 29 (2):833-840 Epub 2020 June 04
    View PubMed
  17. Finney Rutten LJ, Ruddy KJ, Chlan LL, Griffin JM, Herrin J, Leppin AL, Pachman DR, Ridgeway JL, Rahman PA, Storlie CB, Wilson PM, Cheville AL. Pragmatic cluster randomized trial to evaluate effectiveness and implementation of enhanced EHR-facilitated cancer symptom control (E2C2). Trials. 2020 Jun 5; 21 (1):480 Epub 2020 June 05
    View PubMed
  18. Le-Rademacher J, Kanwar R, Seisler D, Pachman DR, Qin R, Abyzov A, Ruddy KJ, Banck MS, Lavoie Smith EM, Dorsey SG, Aaronson NK, Sloan J, Loprinzi CL, Beutler AS. Patient-reported (EORTC QLQ-CIPN20) versus physician-reported (CTCAE) quantification of oxaliplatin- and paclitaxel/carboplatin-induced peripheral neuropathy in NCCTG/Alliance clinical trials. Support Care Cancer. 2017 Nov; 25 (11):3537-3544 Epub 2017 June 20
    View PubMed
  19. Pachman DR, Dockter T, Zekan PJ, Fruth B, Ruddy KJ, Ta LE, Lafky JM, Dentchev T, Le-Lindqwister NA, Sikov WM, Staff N, Beutler AS, Loprinzi CL. A pilot study of minocycline for the prevention of paclitaxel-associated neuropathy: ACCRU study RU221408I. Support Care Cancer. 2017 Nov; 25 (11):3407-3416 Epub 2017 May 27
    View PubMed
  20. Pachman DR, Qin R, Seisler D, Smith EM, Kaggal S, Novotny P, Ruddy KJ, Lafky JM, Ta LE, Beutler AS, Wagner-Johnston ND, Staff NP, Grothey A, Dougherty PM, Cavaletti G, Loprinzi CL. Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505). Support Care Cancer. 2016 Dec; 24 (12):5059-5068 Epub 2016 Aug 18
    View PubMed
  21. Majithia N, Smith TJ, Coyne PJ, Abdi S, Pachman DR, Lachance D, Shelerud R, Cheville A, Basford JR, Farley D, O'Neill C, Ruddy KJ, Sparadeo F, Beutler A, Loprinzi CL. Scrambler Therapy for the management of chronic pain. Support Care Cancer. 2016 Jun; 24 (6):2807-14 Epub 2016 Apr 04
    View PubMed
  22. Zimmerman C, Atherton PJ, Pachman D, Seisler D, Wagner-Johnston N, Dakhil S, Lafky JM, Qin R, Grothey A, Loprinzi CL. MC11C4: a pilot randomized, placebo-controlled, double-blind study of venlafaxine to prevent oxaliplatin-induced neuropathy. Support Care Cancer. 2016 Mar; 24 (3):1071-8 Epub 2015 Aug 08
    View PubMed
  23. Shinde SS, Seisler D, Soori G, Atherton PJ, Pachman DR, Lafky J, Ruddy KJ, Loprinzi CL. Can pregabalin prevent paclitaxel-associated neuropathy?--An ACCRU pilot trial. Support Care Cancer. 2016 Feb; 24 (2):547-553 Epub 2015 July 09
    View PubMed
  24. Pachman DR, Qin R, Seisler DK, Smith EM, Beutler AS, Ta LE, Lafky JM, Wagner-Johnston ND, Ruddy KJ, Dakhil S, Staff NP, Grothey A, Loprinzi CL. Clinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance). J Clin Oncol. 2015 Oct 20; 33 (30):3416-22 Epub 2015 Aug 17
    View PubMed
  25. Pachman DR, Ruddy K, Sangaralingham LR, Grothey A, Shah ND, Beutler AS, Hubbard JM, Loprinzi CL. Calcium and Magnesium Use for Oxaliplatin-Induced Neuropathy: A Case Study to Assess How Quickly Evidence Translates Into Practice. J Natl Compr Canc Netw. 2015 Sep; 13 (9):1097-101
    View PubMed
  26. Pachman DR, Weisbrod BL, Seisler DK, Barton DL, Fee-Schroeder KC, Smith TJ, Lachance DH, Liu H, Shelerud RA, Cheville AL, Loprinzi CL. Pilot evaluation of Scrambler therapy for the treatment of chemotherapy-induced peripheral neuropathy. Support Care Cancer. 2015 Apr; 23 (4):943-51 Epub 2014 Sept 24
    View PubMed
  27. Pachman DR, Watson JC, Loprinzi CL. Therapeutic strategies for cancer treatment related peripheral neuropathies. Curr Treat Options Oncol. 2014 Dec; 15 (4):567-80
    View PubMed
  28. Pachman DR, Price KA, Carey EC. Nonpharmacologic approach to fatigue in patients with cancer. Cancer J. 2014 Sep-Oct; 20(5):313-8.
    View PubMed
  29. Pachman DR, Watson JC, Lustberg MB, Wagner-Johnston ND, Chan A, Broadfield L, Cheung YT, Steer C, Storey DJ, Chandwani KD, Paice J, Jean-Pierre P, Oh J, Kamath J, Fallon M, Strik H, Koeppen S, Loprinzi CL. Management options for established chemotherapy-induced peripheral neuropathy. Support Care Cancer. 2014 Aug; 22 (8):2281-95 Epub 2014 May 31
    View PubMed
  30. Pachman DR, Loprinzi CL, Novotny PJ, Satele DV, Linquist BM, Wolf S, Barton DL. Sternal skin conductance: a reasonable surrogate for hot flash measurement? Menopause. 2013 Nov; 20 (11):1164-8
    View PubMed
  31. Pachman DR, Barton DL, Swetz KM, Loprinzi CL. Troublesome symptoms in cancer survivors: fatigue, insomnia, neuropathy, and pain. J Clin Oncol. 2012 Oct 20; 30 (30):3687-96 Epub 2012 Sept 24
    View PubMed
  32. Gostout BS, Pachman DR, Lechner R. Recognizing and treating ovarian cancer. Minn Med. 2012 Mar; 95(3):40-2.
    View PubMed
  33. Barton DL, Pachman DR. Clinical trials in integrative therapies. Semin Oncol Nurs. 2012 Feb; 28(1):10-28.
    View PubMed
  34. Pachman DR, Barton DL, Clayton AC, McGovern RM, Jefferies JA, Novotny PJ, Sloan JA, Loprinzi CL, Gostout BS. Randomized clinical trial of imiquimod: an adjunct to treating cervical dysplasia. Am J Obstet Gynecol. 2012 Jan; 206 (1):42.e1-7 Epub 2011 July 13
    View PubMed
  35. Pachman DR, Barton DL, Watson JC, Loprinzi CL. Chemotherapy-induced peripheral neuropathy: prevention and treatment. Clin Pharmacol Ther. 2011 Sep; 90 (3):377-87 Epub 2011 Aug 03
    View PubMed
  36. Pachman DR, Barton D, Carns PE, Novotny PJ, Wolf S, Linquist B, Kohli S, Smith DR, Loprinzi CL. Pilot evaluation of a stellate ganglion block for the treatment of hot flashes. Support Care Cancer. 2011 Jul; 19 (7):941-7 Epub 2010 May 23
    View PubMed
  37. Pachman DR, Swetz KM, Mauck WD, Pingree MJ, Hoelzer BC, Haugland AJ, Novotny PJ, Sloan JA, Moynihan TJ, Rho RH. An exploratory pilot study of palliative medicine compared to anesthesia-pain consultation for pain in patients with cancer. J Support Oncol. 2011 May-Jun; 9 (3):113-9
    View PubMed
  38. Pachman DR, Morrison TB, Szostek JH. 84-year-old man with respiratory distress and abdominal distention. Mayo Clin Proc. 2011 Feb; 86 (2):e10-3
    View PubMed
  39. Pachman DR, Jones JM, Loprinzi CL. Management of menopause-associated vasomotor symptoms: Current treatment options, challenges and future directions. Int J Womens Health. 2010 Aug 9; 2:123-35 Epub 2010 Aug 09
    View PubMed